In vitro activity of trovafloxacin on ciprofloxacin-resistant Acinetibacter spp. interactions with meropenem on A-baumannii

被引：0
|
作者：
Giamarellos-Bourboulis, EJ [1 ]
Grecka, P [1 ]
Giamarellou, H [1 ]
机构：
[1] Athens Med Sch, Dept Internal Med 4, Athens, Greece
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P58
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] In vitro evaluation of anti-fungal activity of tropicamide against strains of Candida spp. resistant to fluconazole in planktonic and biofilm form
    Machado, C. B.
    da Silva, C. Rocha
    Barroso, F. Daiana
    Campos, R. D. S.
    Valente Sa, L. G. D. A.
    Aires do Nascimento, F. B. S.
    Cavalcanti, B. C.
    Nobre Junior, H. Vitoriano
    Andrade Neto, J. B.
    JOURNAL DE MYCOLOGIE MEDICALE, 2021, 31 (01):
  • [42] In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
    Nelson, Kirk
    Rubio-Aparicio, Debora
    Tsivkovski, Ruslan
    Sun, Dongxu
    Totrov, Maxim
    Dudley, Michael
    Lomovskayaa, Olga
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [43] In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti, Patricia
    Scheid, Liliane Alves
    Spader, Tatiana Borba
    Atayde, Margareth Linde
    Santurio, Janio Morais
    Alves, Sydney Hartz
    CANADIAN JOURNAL OF MICROBIOLOGY, 2008, 54 (11) : 950 - 956
  • [44] In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp
    Yoneda, Aki
    Thanert, Robert
    Burnham, Carey-Ann D.
    Dantas, Gautam
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
  • [45] In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
    Woodford, Neil
    Pike, Rachel
    Meunier, Daniele
    Loy, Richard
    Hill, Robert
    Hopkins, Katie L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 564 - 567
  • [46] In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens
    Soriano, F
    Fernández-Roblas, R
    Calvo, R
    García-Calvo, G
    Pardeiro, M
    Bryskier, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) : 647 - 649
  • [47] Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
    Hackel, Meredith
    Kazmierczak, Krystyna M.
    Hoban, Daryl J.
    Biedenbach, Douglas J.
    Bouchillon, Samuel K.
    de Jonge, Boudewijn L. M.
    Stone, Gregory G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4677 - 4683
  • [48] In vitro activity of ibrexafungerp (formerly SCY-078) against Candida spp. (including fluconazole-resistant isolates) in development for the treatment of vulvovaginal candidiasis
    Borroto-Esoda, K.
    Barat, S.
    Angulo, D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06) : 689 - 690
  • [49] IN VITRO ACTIVITY OF DAPTOMYCIN AND PRULIFLOXACIN AGAINST MULTI-DRUGS RESISTANT STAPHYLOCOCCUS AND ENTEROCOCCUS SPP. ISOLATED FROM RECURRENT URINARY TRACT INFECTION PATIENTS
    Mazzoli, S.
    Cai, T.
    Meacci, F.
    Malossini, G.
    Bartoletti, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 163 - 163
  • [50] In vitro activity of three commercial bacteriophage cocktails against multidrug-resistant Escherichia coli and Proteus spp. strains of human and non-human origin
    Bernasconi, Odette J.
    Dona, Valentina
    Tinguely, Regula
    Endimiani, Andrea
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 8 : 179 - 185
12345